ketoconazole in the treatment of central serous chorioretinopathy
نویسندگان
چکیده
purpose : the aim of this study is to measure the endogenous cortisol levels in the patients with central serous chorioretinopathy (cscr) and also, evaluate the short-term effect of oral ketoconazole in the treatment of both acute and chronic cscr. methods : in this prospective interventional case series 12 patients with acute cscr and 7 patients with chronic cscr (including one patient with bilateral chronic disease) were treated with oral ketoconazole 200 mg two times per day. measurement of best corrected visual acuity (bcva), macular thickness [using optical coherence tomography (oct)], and 24-hour urinary cortisol levels were done before and after one month of treatment. results : abnormal elevated levels of 24-hour urinary cortisol were identified in 50% of cases at presentation and it reduced after treatment (p=0.03). in acute cscr patients, pretreatment mean logmar bcva was 0.3±0.2 and improved to 0.1±0.1 after treatment (p=0.005). also central macular thickness was significantly reduced after treatment (p=0.001). complete or partial improvement in central macular thickness and bcva were happened in four from eight eyes with chronic cscr. conclusion : oral ketoconazole (400 mg/day) may be a noninvasive and safe therapeutic option for patients with acute cscr and may alter the clinical course of some patients with chronic disease. iranian journal of ophthalmology 201022(4):59-65 © 2010 by the iranian society of ophthalmology
منابع مشابه
Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study.
PURPOSE The aim of this study was to evaluate a possible effect of systemic ketoconazole on visual acuity (VA) and retinal thickness in patients with acute central serous chorioretinopathy (CSCR). METHODS Fifteen consecutive patients were treated with ketoconazole 200 mg/day for a period of 4 weeks. Another 15 patients served as a control group. Baseline examination and review after 4 weeks i...
متن کاملCentral serous chorioretinopathy complicating systemic corticosteroid treatment.
Central serous chorioretinopathy developed in 2 cases of retrobulbar neuritis during systemic treatment with corticosteroids. Fluorescein angiography confirmed leakage surrounded by central serous detachment of the retina. In one case the central serous chorioretinopathy recurred 3 times during 3 separate courses of treatment. Spontaneous recovery accompanied a reduction in steroid treatment to...
متن کاملAtypical Central Serous Chorioretinopathy
Bullous central serous chorioretinopathy (CSCR) is a rare variant of CSCR characterized by severe serous retinal detachment which especially involves the inferior quadrants. Corticosteroid therapy administered for systemic or ocular misdiagnoses may induce and exacerbate CSCR. The purpose of this study was to report diagnosis and treatment results of an unusual case of bullous CSCR induced by s...
متن کاملCentral serous chorioretinopathy.
BACKGROUND Central serous chorioretinopathy is a condition typically affecting young adults between 25 and 50 years of age. It is predominating in type A personality trait men. Central serous chorioretinopathy is defined clinically as a detachment of the sensory retina that is commonly unilateral but can also be bilateral. Laser photocoagulation has been used widely with central serous choriore...
متن کاملCentral serous chorioretinopathy.
The pathogenesis of central serous chorioretinopathy (CSC) is still not fully understood. The involvement of corticosteroids is undisputed, although their exact role has not been clarified; other parts of the underlying mechanism of CSC have been mainly elucidated by imaging techniques such as fluorescein and indocyanine green angiography. Even though most cases of CSC are self-limiting, severe...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
journal of current ophthalmologyجلد ۲۲، شماره ۴، صفحات ۵۹-۶۵
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023